Organogenesis Holdings Inc.

Organogenesis Holdings Inc., formerly Avista Healthcare Public Acquisition Corp. (Nasdaq: AHPA), completed its SPAC merger in late 2018, combining with Organogenesis Inc., a Canton, Massachusetts-based regenerative medicine company specializing in advanced wound care and surgical biologics. The SPAC was sponsored by Avista Capital Holdings LP and conducted its IPO in 2016. The October 2018 8-K filing documented a key milestone in the de-SPAC transaction that brought the combined entity to the public markets under the ticker ORGO on the Nasdaq. The company operates in the healthcare sector, with a product portfolio targeting chronic and acute wound management. Visit SpacDesk and sign up for full access to SPAC transaction data, sponsor profiles, and deal timelines.